Report Detail

Pharma & Healthcare COVID-19 Impact on Global Primaquine, Market Insights and Forecast to 2026

  • RnM4073433
  • |
  • 23 June, 2020
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Primaquine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Primaquine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Primaquine market is segmented into
Injectables
Capsules
Tablets

Segment by Application, the Primaquine market is segmented into
Hospital
Clinic
Laboratory
Others

Regional and Country-level Analysis
The Primaquine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Primaquine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Primaquine Market Share Analysis
Primaquine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Primaquine business, the date to enter into the Primaquine market, Primaquine product introduction, recent developments, etc.
The major vendors covered:
Cyper Pharma
Santa Cruz Biotechnology
Pfizer
Summit Medical Group
...


1 Study Coverage

  • 1.1 Primaquine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Primaquine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Primaquine Market Size Growth Rate by Type
    • 1.4.2 Injectables
    • 1.4.3 Capsules
    • 1.4.4 Tablets
  • 1.5 Market by Application
    • 1.5.1 Global Primaquine Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Laboratory
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Primaquine Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Primaquine Industry
      • 1.6.1.1 Primaquine Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Primaquine Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Primaquine Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Primaquine Market Size Estimates and Forecasts
    • 2.1.1 Global Primaquine Revenue 2015-2026
    • 2.1.2 Global Primaquine Sales 2015-2026
  • 2.2 Primaquine Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Primaquine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Primaquine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Primaquine Competitor Landscape by Players

  • 3.1 Primaquine Sales by Manufacturers
    • 3.1.1 Primaquine Sales by Manufacturers (2015-2020)
    • 3.1.2 Primaquine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Primaquine Revenue by Manufacturers
    • 3.2.1 Primaquine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Primaquine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Primaquine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Primaquine Revenue in 2019
    • 3.2.5 Global Primaquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Primaquine Price by Manufacturers
  • 3.4 Primaquine Manufacturing Base Distribution, Product Types
    • 3.4.1 Primaquine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Primaquine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Primaquine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Primaquine Market Size by Type (2015-2020)
    • 4.1.1 Global Primaquine Sales by Type (2015-2020)
    • 4.1.2 Global Primaquine Revenue by Type (2015-2020)
    • 4.1.3 Primaquine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Primaquine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Primaquine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Primaquine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Primaquine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Primaquine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Primaquine Market Size by Application (2015-2020)
    • 5.1.1 Global Primaquine Sales by Application (2015-2020)
    • 5.1.2 Global Primaquine Revenue by Application (2015-2020)
    • 5.1.3 Primaquine Price by Application (2015-2020)
  • 5.2 Primaquine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Primaquine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Primaquine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Primaquine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Primaquine by Country
    • 6.1.1 North America Primaquine Sales by Country
    • 6.1.2 North America Primaquine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Primaquine Market Facts & Figures by Type
  • 6.3 North America Primaquine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Primaquine by Country
    • 7.1.1 Europe Primaquine Sales by Country
    • 7.1.2 Europe Primaquine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Primaquine Market Facts & Figures by Type
  • 7.3 Europe Primaquine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Primaquine by Region
    • 8.1.1 Asia Pacific Primaquine Sales by Region
    • 8.1.2 Asia Pacific Primaquine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Primaquine Market Facts & Figures by Type
  • 8.3 Asia Pacific Primaquine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Primaquine by Country
    • 9.1.1 Latin America Primaquine Sales by Country
    • 9.1.2 Latin America Primaquine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Primaquine Market Facts & Figures by Type
  • 9.3 Central & South America Primaquine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Primaquine by Country
    • 10.1.1 Middle East and Africa Primaquine Sales by Country
    • 10.1.2 Middle East and Africa Primaquine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Primaquine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Primaquine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Cyper Pharma
    • 11.1.1 Cyper Pharma Corporation Information
    • 11.1.2 Cyper Pharma Description, Business Overview and Total Revenue
    • 11.1.3 Cyper Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Cyper Pharma Primaquine Products Offered
    • 11.1.5 Cyper Pharma Recent Development
  • 11.2 Santa Cruz Biotechnology
    • 11.2.1 Santa Cruz Biotechnology Corporation Information
    • 11.2.2 Santa Cruz Biotechnology Description, Business Overview and Total Revenue
    • 11.2.3 Santa Cruz Biotechnology Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Santa Cruz Biotechnology Primaquine Products Offered
    • 11.2.5 Santa Cruz Biotechnology Recent Development
  • 11.3 Pfizer
    • 11.3.1 Pfizer Corporation Information
    • 11.3.2 Pfizer Description, Business Overview and Total Revenue
    • 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Pfizer Primaquine Products Offered
    • 11.3.5 Pfizer Recent Development
  • 11.4 Summit Medical Group
    • 11.4.1 Summit Medical Group Corporation Information
    • 11.4.2 Summit Medical Group Description, Business Overview and Total Revenue
    • 11.4.3 Summit Medical Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Summit Medical Group Primaquine Products Offered
    • 11.4.5 Summit Medical Group Recent Development
  • 11.1 Cyper Pharma
    • 11.1.1 Cyper Pharma Corporation Information
    • 11.1.2 Cyper Pharma Description, Business Overview and Total Revenue
    • 11.1.3 Cyper Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Cyper Pharma Primaquine Products Offered
    • 11.1.5 Cyper Pharma Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Primaquine Market Estimates and Projections by Region
    • 12.1.1 Global Primaquine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Primaquine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Primaquine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Primaquine Sales Forecast (2021-2026)
    • 12.2.2 North America: Primaquine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Primaquine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Primaquine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Primaquine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Primaquine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Primaquine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Primaquine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Primaquine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Primaquine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Primaquine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Primaquine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Primaquine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Primaquine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Primaquine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Primaquine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Primaquine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Primaquine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Primaquine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Primaquine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Primaquine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Primaquine. Industry analysis & Market Report on COVID-19 Impact on Global Primaquine is a syndicated market report, published as COVID-19 Impact on Global Primaquine, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Primaquine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,065.40
    4,598.10
    6,130.80
    3,685.50
    5,528.25
    7,371.00
    605,280.00
    907,920.00
    1,210,560.00
    329,316.00
    493,974.00
    658,632.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report